Cargando…

Healthcare costs and resource utilization of asthma in Germany: a claims data analysis

INTRODUCTION: Asthma is associated with a substantial economic burden on the German Statutory Health Insurance. AIMS AND OBJECTIVES: To determine costs and resource utilization associated with asthma and to analyze the impact of disease severity on subgroups based on age and gender. METHODS: A claim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jacob, Christian, Bechtel, Benno, Engel, Susanne, Kardos, Peter, Linder, Roland, Braun, Sebastian, Greiner, Wolfgang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2015
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757601/ https://www.ncbi.nlm.nih.gov/pubmed/25716136 http://dx.doi.org/10.1007/s10198-015-0671-3

Ejemplares similares

Assessing asthma severity based on claims data: a systematic review
por: Jacob, Christian, et al.
Publicado: (2016)

Healthcare Resource Utilization and Cost of Patients with Multiple Myeloma in Germany: A Retrospective Claims Data Analysis
por: Kocaata, Zeki, et al.
Publicado: (2022)

Healthcare resource utilization and costs in 23–25-year-old women with human papillomavirus (HPV) associated anogenital diseases in Germany – a retrospective analysis of statutory health insurance claims data
por: Reuschenbach, Miriam, et al.
Publicado: (2022)

Epidemiology and cost of seasonal influenza in Germany - a claims data analysis
por: Scholz, Stefan, et al.
Publicado: (2019)

Healthcare Resource Utilization and Costs in Celiac Disease: A US Claims Analysis
por: Cappell, Katherine, et al.
Publicado: (2020)

Burden of sequelae and healthcare resource utilization in the first year of life in infants born with congenital cytomegalovirus (cCMV) infection in Germany: A retrospective statutory health insurance claims database analysis
por: de Lepper, Marion, et al.
Publicado: (2023)

Healthcare Resource Utilization and Cost Burden of BCG-Treated Non-Muscle Invasive Bladder Cancer Patients in Germany: A Retrospective Claims Analysis
por: Quignot, Nadia, et al.
Publicado: (2023)

Healthcare Utilization and Costs of Systemic Lupus Erythematosus in Medicaid
por: Kan, Hong J., et al.
Publicado: (2013)

Estimating Colorectal Cancer Treatment Costs: A Pragmatic Approach Exemplified by Health Insurance Data from Germany
por: Haug, Ulrike, et al.
Publicado: (2014)

Health care costs and resource utilization for different asthma severity stages in Colombia: a claims data analysis
por: Flórez-Tanus, Álvaro, et al.
Publicado: (2018)

Healthcare resource utilization and costs among nonalcoholic fatty liver disease patients in Germany
por: Canbay, Ali, et al.
Publicado: (2021)

Healthcare resource utilization and costs associated with incremental systemic corticosteroid exposure in asthma
por: Voorham, Jaco, et al.
Publicado: (2018)

Healthcare Costs and Resource Use Associated With Cervical Intraepithelial Neoplasia and Cervical Conization: A Retrospective Study of German Statutory Health Insurance Claims Data
por: Stephan, Anna-Janina, et al.
Publicado: (2022)

Healthcare resource utilization and cost of pneumococcal disease in children in Germany, 2014–2019: a retrospective cohort study
por: Hu, Tianyan, et al.
Publicado: (2023)

Comparison Of Methods To Estimate Disease-Related Cost And Healthcare Resource Utilization For Autoimmune Diseases In Administrative Claims Databases
por: Schroeder, Krista M, et al.
Publicado: (2019)

Health care utilizations and costs of Campylobacter enteritis in Germany: A claims data analysis
por: Schorling, Elisabeth, et al.
Publicado: (2023)

Burden of HPV related anogenital diseases in young women in Germany – an analysis of German statutory health insurance claims data from 2012 to 2017
por: Reuschenbach, Miriam, et al.
Publicado: (2020)

Healthcare costs and resource utilisation in bronchiectasis, asthma and COPD
por: Ronco, Raffaella, et al.
Publicado: (2023)

Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA
por: Olson, Amy L., et al.
Publicado: (2020)

Treatment Changes, Healthcare Resource Utilization, and Costs Among Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy: A Claims Database Study
por: Owens, Anjali T., et al.
Publicado: (2022)

Healthcare resource use and costs of multiple sclerosis patients in Germany before and during fampridine treatment
por: Ziemssen, Tjalf, et al.
Publicado: (2017)

Estimates of Toxoplasmosis Incidence Based on Healthcare Claims Data, Germany, 2011–2016
por: Krings, Amrei, et al.
Publicado: (2021)

Trends and regional distribution of outpatient claims for asthma, 2009–2016, Germany
por: Akmatov, Manas K, et al.
Publicado: (2020)

Healthcare costs and utilization of diabetes-related complications in Taiwan: A claims database analysis
por: Cheng, Ssu-Wei, et al.
Publicado: (2018)

Treatment-Related Healthcare Costs of Metastatic Castration-Resistant Prostate Cancer in Germany: A Claims Data Study
por: Kreis, Kristine, et al.
Publicado: (2020)

Treatment Patterns and Resource Utilization of Pregnant Women with Inflammatory Rheumatic Diseases or Psoriasis in Germany: A Claims Database Analysis
por: Blaschke, Katja, et al.
Publicado: (2021)

The Burden of Systemic Lupus Erythematosus in Germany: Incidence, Prevalence, and Healthcare Resource Utilization
por: Schwarting, Andreas, et al.
Publicado: (2021)

Healthcare resource utilization, total costs, and comorbidities among patients with myotonic dystrophy using U.S. insurance claims data from 2012 to 2019
por: Howe, Sarah J., et al.
Publicado: (2022)

Healthcare Resource Utilization and Related Costs in Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype: A US Claims Database Analysis
por: Olson, Amy L., et al.
Publicado: (2022)

Healthcare Resource Utilization and Associated Costs of German Patients with Diffuse Large B-Cell Lymphoma: A Retrospective Health Claims Data Analysis
por: Borchmann, Peter, et al.
Publicado: (2022)

Complications, Costs, and Healthcare Resource Utilization After Staged, Delayed, and Immediate Free-Flap Breast Reconstruction: A Longitudinal, Claims-Based Analysis
por: Shammas, Ronnie L., et al.
Publicado: (2022)

Healthcare costs of congenital cytomegalovirus (cCMV) disease in infants during the first two years of life: a retrospective German claims database analysis
por: Stephan, Anna-Janina, et al.
Publicado: (2023)

Treatment patterns and healthcare resource utilization in palmoplantar pustulosis patients in Japan: A claims database study
por: Miyazaki, Celine, et al.
Publicado: (2020)

Alopecia Areata Treatment Patterns, Healthcare Resource Utilization, and Comorbidities in the US Population Using Insurance Claims
por: Senna, Maryanne, et al.
Publicado: (2021)

One-year follow-up healthcare costs of patients diagnosed with skin cancer in Germany: a claims data analysis
por: Speckemeier, Christian, et al.
Publicado: (2022)

Correction: Healthcare resource utilization, total costs, and comorbidities among patients with myotonic dystrophy using U.S. insurance claims data from 2012 to 2019
por: Howe, Sarah J., et al.
Publicado: (2022)

Treatment patterns, healthcare resource utilization, and costs in patients with moderate‐to‐severe psoriasis treated with systemic therapy in Japan: A retrospective claims database study
por: Tada, Yayoi, et al.
Publicado: (2022)

Evaluation of treatment patterns, healthcare resource utilization and cost of illness for sickle cell disease in Ghana: a private medical insurance claims database study
por: Marfo, Kwaku, et al.
Publicado: (2023)

Impact of Endometriosis Diagnostic Delays on Healthcare Resource Utilization and Costs
por: Surrey, Eric, et al.
Publicado: (2020)

Healthcare resource utilization and costs associated with anogenital warts in Morocco
por: Berrada, Myriam, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7g2u32ghum7fo22do670k2cuk9